270 articles
Kleo Pharmaceuticals is a unique immuno-oncology company poised to solve some of the problems dominating the headlines for the biopharmaceutical industry.
Kate Mangione discusses a study recently published in JAMA that looked at the effects of home-based physical therapy on elderly hip fracture patients.
Dawn Marie Stull PharmD., BCOP scientific director and lead of INSIGHT MM at Takeda Oncology, discusses the INSIGHT MM (multiple myeloma) study, the lar...
Crystal talks about why the opioid crisis has become a fentanyl crisis and an antidote to protect against a fentanyl attack.
Cutler discusses the scientific basis for the host of side effects that can accompany current antipsychotics for treating schizophrenia.
Joe Reynolds leverages the knowledge of the pharmaceutical and medical device industries to derive insights and maximize value for all members of the No...
As of June 11, 2019, Merck's KEYTRUDA is now FDA approved for first-line treatment of patients with metastatic or with unresectable, recurrent head and ...
Gerard Clum, D.C., Board Member of the Foundation for Chiropractic Progress, addresses the issues surrounding neck manipulation and strokes.
Mike Davis, Head of Neurology for UCB, a global biopharmaceutical company in the U.S., discusses the recent FDA approval of NAYZILAM® (midazolam) for t...
John Incledon, President of Hisamitsu America (the makers of Salonpas patches), discusses the Centers for Disease Control's recent recommendation for ph...